The role of UV induced lesions in skin carcinogenesis: An overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 571, Issue 1-2 SPEC. ISS., 2005, Pages 43-56

  Daya Grosjean, Leela ^a   Sarasin, Alain ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

DNA repair; Mutation; Oncogene; Skin tumor; Tumor suppressor gene; UV; Xeroderma pigmentosum

Indexed keywords

ARF PROTEIN; INK; NUCLEOTIDE; PROTEIN P53; PYRIMIDINE;

BASAL CELL CARCINOMA; CARCINOGENESIS; DNA DAMAGE; DNA REPAIR; DNA STRAND; EXCISION REPAIR; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC STABILITY; HEDGEHOG; HOMEOSTASIS; HUMAN; MELANOMA; MITOGENESIS; ONCOGENE; ONCOGENE RAS; PERCEPTION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN TUMOR; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; VALIDATION PROCESS; XERODERMA PIGMENTOSUM;

EID: 14644430466     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.11.013     Document Type: Review

References (77)

1. J.H. Hoeijmakers Genome maintenance mechanisms for preventing cancer Nature 411 2001 366 374
2. E.C. Friedberg How nucleotide excision repair protects against cancer Nat. Rev. Cancer 1 2001 22 33
3. A.R. Lehmann DNA repair-deficient diseases, xeroderma pigmentosum Cockayne syndrome and trichothiodystrophy Biochimie 85 2003 1101 1111
4. A. Stary, and A. Sarasin The genetics of the hereditary xeroderma pigmentosum syndrome Biochimie 84 2002 49 60
5. F.R. de Gruijl Skin cancer and solar UV radiation Eur. J. Cancer 35 1999 2003 2009
6. Y. Matsumura, and H.N. Ananthaswamy Molecular mechanisms of photocarcinogenesis Front. Biosci. 7 2002 d765 d783
7. J.C. van der Leun, and F.R. de Gruijl Climate change and skin cancer Photochem. Photobiol. Sci. 1 2002 324 326
8. F.R. de Gruijl, J. Longstreth, M. Norval, A.P. Cullen, H. Slaper, M.L. Kripke, Y. Takizawa, and J.C. van der Leun Health effects from stratospheric ozone depletion and interactions with climate change Photochem. Photobiol. Sci. 2 2003 16 28
9. A.A. Gaspari, T.A. Fleisher, and K.H. Kraemer Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum J. Clin. Invest. 92 1993 1135 1142
10. A. Stary, and A. Sarasin Molecular mechanisms of UV induced mutations as revealed by the study of DNA polymerase eta in human cells Res. Microbiol. 153 2002 441 445
11. H. van Steeg, and K.H. Kraemer Xeroderma pigmentosum and the role of UV induced DNA damage in skin cancer Mol. Med. Today 5 1999 86 94
12. S. Moriwaki, and K.H. Kraemer Xeroderma pigmentosum - bridging a gap between clinic and laboratory Photodermatol. Photoimmunol. Photomed. 17 2001 47 54
13. H. Takebe, C. Nishigori, and K. Tatsumi Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells J. Invest. Dermatol. 92 1989 236S 238S
14. K.H. Kraemer, M.M. Lee, A.D. Andrews, and W.C. Lambert The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm Arch. Dermatol. 130 1994 1018 1021
15. A. Sarasin The molecular pathways of ultraviolet-induced carcinogenesis Mutat. Res. 428 1999 5 10
16. A. Sarasin An overview of the mechanisms of mutagenesis and carcinogenesis Mutat. Res. 544 2003 99 106
17. K.W. Kinzler, and B. Vogelstein Cancer-susceptibility genes. Gatekeepers and caretakers Nature 386 1997 761 763
18. H.G. Suarez, L. Daya-Grosjean, D. Schlaifer, P. Nardeux, G. Renault, J.L. Bos, and A. Sarasin Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum Cancer Res. 49 1989 1223 1228
19. M. Sato, C. Nishigori, Y. Lu, M. Zghal, T. Yagi, and H. Takebe Far less frequent mutations in ras genes than in the p53 gene in skin tumors of xeroderma pigmentosum patients Mol. Carcinog. 11 1994 98 105
20. K. Ishizaki, T. Tsujimura, M. Nakai, C. Nishigori, K. Sato, S. Katayama, O. Kurimura, K. Yoshikawa, S. Imamura, and M. Ikenaga Infrequent mutation of the ras genes in skin tumors of xeroderma pigmentosum patients in Japan Int. J. Cancer 50 1992 382 385
21. L. Daya-Grosjean, C. Robert, C. Drougard, H. Suarez, and A. Sarasin High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients Cancer Res. 53 1993 1625 1629
22. K. Omholt, A. Platz, L. Kanter, U. Ringborg, and J. Hansson NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression Clin. Cancer Res. 9 2003 6483 6488
23. J. Reifenberger, C.B. Knobbe, A.A. Sterzinger, B. Blaschke, K.W. Schulte, T. Ruzicka, G. Reifenberger, K. Omholt, A. Platz, L. Kanter, U. Ringborg, and J. Hansson Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression Int. J. Cancer 109 2004 377 384
24. N. Motoyama, and K. Naka DNA damage tumor suppressor genes and genomic instability Curr. Opin. Genet. Dev. 14 2004 11 16
25. M. Olivier, S.P. Hussain, C. Caron de Fromentel, P. Hainaut, and C.C. Harris TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer IARC Sci. Publ. 2004 247 270
26. W.H. Liggett Jr., and D. Sidransky Role of the p16 tumor suppressor gene in cancer J. Clin. Oncol. 16 1998 1197 1206
27. M. Ruas, and G. Peters The p16INK4a/CDKN2A tumor suppressor and its relatives Biochim. Biophys. Acta 1378 1998 115 177
28. H. Nakazawa, D. English, P.L. Randell, K. Nakazawa, N. Martel, B.K. Armstrong, and H. Yamasaki UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement Proc. Natl. Acad. Sci. U.S.A. 91 1994 360 364
29. A.S. Jonason, S. Kunala, G.J. Price, R.J. Restifo, H.M. Spinelli, J.A. Persing, D.J. Leffell, R.E. Tarone, and D.E. Brash Frequent clones of p53-mutated keratinocytes in normal human skin Proc. Natl. Acad. Sci. U.S.A. 93 1996 14025 14029
30. G. Ling, A. Persson, B. Berne, M. Uhlen, J. Lundeberg, and F. Ponten Persistent p53 mutations in single cells from normal human skin Am. J. Pathol. 159 2001 1247 1253
31. C. Williams, F. Ponten, A. Ahmadian, Z.P. Ren, G. Ling, O. Rollman, A. Ljung, N.G. Jaspers, M. Uhlen, J. Lundeberg, and J. Ponten Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient Cancer Res. 58 1998 2449 2455
32. N. Dumaz, C. Drougard, A. Sarasin, and L. Daya-Grosjean Specific UV induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients Proc. Natl. Acad. Sci. U.S.A. 90 1993 10529 10533
33. M. Sato, C. Nishigori, M. Zghal, T. Yagi, and H. Takebe Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients Cancer Res. 53 1993 2944 2946
34. Y. Matsumura, M. Sato, C. Nishigori, M. Zghal, T. Yagi, S. Imamura, and H. Takebe High prevalence of mutations in the p53 gene in poorly differentiated squamous cell carcinomas in xeroderma pigmentosum patients J. Invest. Dermatol. 105 1995 399 401
35. G. Giglia, N. Dumaz, C. Drougard, M.F. Avril, L. Daya-Grosjean, and A. Sarasin p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C Cancer Res. 58 1998 4402 4409
36. G. Giglia-Mari, and A. Sarasin TP53 mutations in human skin cancers Hum. Mutat. 21 2003 217 228
37. M. D'Errico, A. Calcagnile, F. Canzona, B. Didona, P. Posteraro, R. Cavalieri, R. Corona, I. Vorechovsky, T. Nardo, M. Stefanini, and E. Dogliotti UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients Oncogene 19 2000 463 467
38. A. Spatz, G. Giglia-Mari, S. Benhamou, and A. Sarasin Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum Cancer Res. 61 2001 2480 2486
39. J.M. McGregor, C.A. Harwood, L. Brooks, S.A. Fisher, D.A. Kelly, J. O'Nions, A.R. Young, T. Surentheran, J. Breuer, T.P. Millard, C.M. Lewis, I.M. Leigh, A. Storey, and T. Crook Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer J. Invest. Dermatol. 119 2002 84 90
40. S. Bolshakov, C.M. Walker, S.S. Strom, M.S. Selvan, G.L. Clayman, A. El-Naggar, S.M. Lippman, M.L. Kripke, and H.N. Ananthaswamy Ananthaswamy. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas Clin. Cancer Res. 9 2003 228 234
41. S. Stone, P. Jiang, P. Dayananth, S.V. Tavtigian, H. Katcher, D. Parry, G. Peters, and A. Kamb Complex structure and regulation of the P16 (MTS1) locus Cancer Res. 55 1995 2988 2994
42. S. Bates, A.C. Phillips, P.A. Clark, F. Stott, G. Peters, R.L. Ludwig, and K.H. Vousden p14ARF links the tumour suppressors RB and p53 Nature 395 1998 124 125
43. F.J. Stott, S. Bates, M.C. James, B.B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K.H. Vousden, and G. Peters The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2 EMBO J. 17 1998 5001 5014
44. A.L. Reed, J. Califano, P. Cairns, W.H. Westra, R.M. Jones, W. Koch, S. Ahrendt, Y. Eby, D. Sewell, H. Nawroz, J. Bartek, and D. Sidransky High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma Cancer Res. 56 1996 3630 3633
45. M. Serrano, H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho Role of the INK4a locus in tumor suppression and cell mortality Cell 85 1996 27 37
46. T. Kamijo, F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, and C.J. Sherr Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF Cell 91 1997 649 659
47. Y. Kubo, Y. Urano, K. Matsumoto, K. Ahsan, and S. Arase Mutations of the INK4a locus in squamous cell carcinomas of human skin Biochem. Biophys. Res. Commun. 232 1997 38 41
48. N. Soufir, J.P. Moles, C. Vilmer, C. Moch, O. Verola, J. Rivet, A. Tesniere, L. Dubertret, and N. Basset-Seguin P16 UV mutations in human skin epithelial tumors Oncogene 18 1999 5477 5481
49. V.L. Brown, C.A. Harwood, T. Crook, J.G. Cronin, D.P. Kelsell, and C.M. Proby p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma J. Invest. Dermatol. 122 2004 1284 1292
50. Y. Kubo, Y. Urano, K. Fukuhara, K. Matsumoto, and S. Arase Lack of mutation in the INK4a locus in basal cell carcinomas Br. J. Dermatol. 139 1998 340 341
51. N. Soufir, L. Daya-Grosjean, P. de La Salmoniere, J.P. Moles, L. Dubertret, A. Sarasin, and N. Basset-Seguin Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients J. Natl. Cancer Inst. 92 2000 1841 1847
52. H.T. Lynch, T.G. Shaw, J.F. Lynch, T. Debniak, B. Gorski, R.J. Scott, C. Cybulski, K. Medrek, E. Zowocka, G. Kurzawski, B. Debniak, J. Kadny, S. Bielecka-Grzela, R. Maleszka, and J. Lubinski Inherited predisposition to cancer: a historical overview Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer Am. J. Med. Genet. 129C 2004 5 22
53. J.C. Ehrhart, F.P. Gosselet, R.M. Culerrier, and A. Sarasin UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis Photochem. Photobiol. Sci. 2 2003 825 834
54. J.L. Mullor, P. Sanchez, and A.R. Altaba Pathways and consequences: hedgehog signaling in human disease Trends Cell Biol. 12 2002 562 569
55. A. Ruiz i Altaba, P. Sanchez, and N. Dahmane Gli and hedgehog in cancer: tumours, embryos and stem cells Nat. Rev. Cancer 2 2002 361 372
56. T. Ellis, I. Smyth, E. Riley, J. Bowles, C. Adolphe, J.A. Rothnagel, C. Wicking, and B.J. Wainwright Overexpression of sonic hedgehog suppresses embryonic hair follicle morphogenesis Dev. Biol. 263 2003 203 215
57. R.J. Gorlin Nevoid basal cell carcinoma syndrome Dermatol. Clin. 13 1995 113 125
58. A.E. Bale, and K.P. Yu The hedgehog pathway and basal cell carcinomas Hum. Mol. Genet. 10 2001 757 762
59. M.R. Gailani, M. Stahle-Backdahl, D.J. Leffell, M. Glynn, P.G. Zaphiropoulos, C. Pressman, A.B. Unden, M. Dean, D.E. Brash, A.E. Bale, and R. Toftgard The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas Nat. Genet. 14 1996 78 81
60. A.B. Unden, E. Holmberg, B. Lundh-Rozell, M. Stahle-Backdahl, P.G. Zaphiropoulos, R. Toftgard, and I. Vorechovsky Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation Cancer Res. 56 1996 4562 4565
61. M. Wolter, J. Reifenberger, C. Sommer, T. Ruzicka, and G. Reifenberger Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system Cancer Res. 57 1997 2581 2585
62. M.R. Gailani, and A.E. Bale Developmental genes and cancer: role of patched in basal cell carcinoma of the skin J. Natl. Cancer. Inst. 89 1997 1103 1109
63. M. Aszterbaum, A. Rothman, R.L. Johnson, M. Fisher, J. Xie, J.M. Bonifas, X. Zhang, M.P. Scott, and E.H. Epstein Jr. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome J. Invest. Dermatol. 110 1998 885 888
64. N. Bodak, S. Queille, M.F. Avril, B. Bouadjar, C. Drougard, A. Sarasin, and L. Daya-Grosjean High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum Proc. Natl. Acad. Sci. U.S.A. 96 1999 5117 5122
65. L. Daya-Grosjean, and A. Sarasin UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients Mutat. Res. 450 2000 193 199
66. S. Couve-Privat, B. Bouadjar, M.F. Avril, A. Sarasin, and L. Daya-Grosjean Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients Cancer Res. 62 2002 7186 7189
67. J. Xie, M. Murone, S.M. Luoh, A. Ryan, Q. Gu, C. Zhang, J.M. Bonifas, C.W. Lam, M. Hynes, A. Goddard, A. Rosenthal, E.H. Epstein Jr., and F.J. de Sauvage Activating smoothened mutations in sporadic basal-cell carcinoma Nature 391 1998 90 92
68. J. Reifenberger, M. Wolter, R.G. Weber, M. Megahed, T. Ruzicka, P. Lichter, and G. Reifenberger Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system Cancer Res. 58 1998 1798 1803
69. C.W. Lam, J. Xie, K.F. To, H.K. Ng, K.C. Lee, N.W. Yuen, P.L. Lim, L.Y. Chan, S.F. Tong, and F. McCormick A frequent activated smoothened mutation in sporadic basal cell carcinomas Oncogene 18 1999 833 836
70. S. Couve-Privat, M. Le Bret, E. Traiffort, S. Queille, J. Coulombe, B. Bouadjar, M.F. Avril, M. Ruat, A. Sarasin, and L. Daya-Grosjean Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients Cancer Res. 64 2004 3559 3565
71. A.E. Oro, K.M. Higgins, Z. Hu, J.M. Bonifas, E.H. Epstein Jr., and M.P. Scott Basal cell carcinomas in mice overexpressing sonic hedgehog Science 276 1997 817 821
72. C. Wicking, T. Evans, B. Henk, N. Hayward, L.A. Simms, G. Chenevix-Trench, T. Pietsch, and B. Wainwright No evidence for the H133Y mutation in SONIC HEDGEHOG in a collection of common tumour types Oncogene 16 1998 1091 1093
73. J.A. Porter, D.P. von Kessler, S.C. Ekker, K.E. Young, J.J. Lee, K. Moses, and P.A. Beachy The product of hedgehog autoproteolytic cleavage active in local and long-range signalling Nature 374 1995 363 366
74. J.A. Porter, K.E. Young, and P.A. Beachy Cholesterol modification of hedgehog signaling proteins in animal development Science 274 1996 255 259
75. S. Tommasi, M.F. Denissenko, and G.P. Pfeifer Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases Cancer Res. 57 1997 4727 4730
76. T. Soussi, and C. Beroud Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides Hum. Mutat. 21 2003 192 200
77. M. Aszterbaum, J. Epstein, A. Oro, V. Douglas, P.E. LeBoit, M.P. Scott, and E.H. Epstein Jr. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice Nat. Med. 5 1999 1285 1291